SG Americas Securities’s Intersect ENT, Inc XENT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-20,724
| Closed | -$580K | – | 3700 |
|
|
2022
Q1 | $580K | Buy |
+20,724
| New | +$568K | ﹤0.01% | 1790 |
|
|
2021
Q4 | – | Sell |
-35,179
| Closed | -$957K | – | 3970 |
|
|
2021
Q3 | $957K | Buy |
+35,179
| New | +$870K | ﹤0.01% | 1955 |
|
|
2021
Q2 | – | Sell |
-4,848
| Closed | -$101K | – | 3388 |
|
|
2021
Q1 | $101K | Buy |
+4,848
| New | +$112K | ﹤0.01% | 3087 |
|
|
2020
Q4 | – | Sell |
-33,137
| Closed | -$540K | – | 3535 |
|
|
2020
Q3 | $540K | Buy |
33,137
+14,611
| +79% | +$265K | ﹤0.01% | 1585 |
|
|
2020
Q2 | $251K | Sell |
18,526
-62,465
| -77% | -$727K | ﹤0.01% | 2665 |
|
|
2020
Q1 | $960K | Buy |
80,991
+48,048
| +146% | +$1.07M | 0.01% | 1321 |
|
|
2019
Q4 | $820K | Buy |
32,943
+4,879
| +17% | +$98.9K | 0.01% | 1417 |
|
|
2019
Q3 | $477K | Sell |
28,064
-1,726
| -6% | -$31.4K | ﹤0.01% | 1913 |
|
|
2019
Q2 | $678K | Sell |
29,790
-29,035
| -49% | -$783K | ﹤0.01% | 1700 |
|
|
2019
Q1 | $1.89M | Sell |
58,825
-72,379
| -55% | -$2.24M | 0.02% | 882 |
|
|
2018
Q4 | $3.7M | Buy |
+131,204
| New | +$3.84M | 0.03% | 497 |
|
|
2018
Q2 | – | Sell |
-3,358
| Closed | -$132K | – | 3624 |
|
|
2018
Q1 | $132K | Buy |
+3,358
| New | +$123K | ﹤0.01% | 2737 |
|
SG Americas Securities's XENT Position: Q2 2022 in Review
SG Americas Securities sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 20,724 shares — an estimated $580K sold.
SG Americas Securities first reported a position in XENT in Q1 2018 and held it in 12 quarters. The position peaked at $3.7M in Q4 2018. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.
- SG Americas Securities reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
- SG Americas Securities sold 20,724 Intersect ENT, Inc shares in Q2 2022, an estimated $580K.
- SG Americas Securities first reported a position in Intersect ENT, Inc in Q1 2018 and held it in 12 quarters.
- SG Americas Securities's Intersect ENT, Inc position peaked at $3.7M in Q4 2018.
- 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.
Based on SG Americas Securities's 13F filing for Q2 2022, filed 29 Jul 2022.